https://doi.org/10.4081/hmr.v2i10.443

Impaired innate immune responses in human neonates

Vol. 2 No. 10: Vth International Neonatal Hematology and Immunology Meeting
Published: June 9, 2009
Abstract Views: 139
PDF: 705
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

L Maródi
support@pagepress.org
Human newborns are at greater risk of infection than children and adults because of the immaturity of their immune system. Mononuclear phagocytes from the cord generate blunted responses to an array of toll-like receptor (TLR) ligands and to physiologic stimuli of the inflammatory response. Neonatal deficiency of innate cellular immunity includes a decreased production of interferons, interleukin (IL)-12/IL-23, and IL-18, and other proinflammatory cytokines, an impaired type-1 response of macrophages to IFN-γ, the most potent macrophage-activating agent in vivo, and to lipopolysaccharide, the primary constituent of the outer membrane of Gram-negative bacteria. This review will describe recent advances in understanding innate cellular immunity in human neonates. As we learn more about neonatal innate immunity, new therapeutic avenues may come into sight. Drug development efforts could be directed toward augmenting innate cellular immune responses to prevent and treat neonatal infections more accurately.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Maródi, L. (2009). Impaired innate immune responses in human neonates. Hematology Meeting Reports (formerly Haematologica Reports), 2(10). https://doi.org/10.4081/hmr.v2i10.443
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).